Report
Jonathan Moreland
EUR 9.34 For Business Accounts Only

InsiderInsights.com Daily Ratings Report: March 20, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
Underlyings
America's Car-Mart Inc.

America's Car-Mart is an automotive retailer focused on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart, Inc. and Colonial Auto Finance, Inc. The company primarily sells older model used vehicles and provides financing for substantially all of its customers. The company purchases vehicles primarily from wholesalers, new car dealers, individuals and auctions. The company provides financing to substantially all of its customers who purchase a vehicle at one of its dealerships. A majority of the company's customers make their payments in person at the dealership where they purchased their vehicle.

Citi Trends Inc.

Citi Trends is a retailer of fashion apparel and accessories for the entire family. The company also provides a variety of products from less recognized brands and a lesser amount representing private label products under its brands. The company's merchandise includes apparel, accessories and home. Within apparel, the company provides fashion sportswear for men, women and children, including offerings for newborns, infants, toddlers, boys and girls. Accessories include handbags, jewelry, footwear, belts, intimate apparel, scrubs and sleepwear. Home includes functional bedroom, bathroom and kitchen products, as well as beauty and toys.

Clearside Biomedical Inc

Clearside Biomedical is a biopharmaceutical company developing treatments that restore vision for people with back of the eye diseases. The company's suprachoroidal injection platform is a patented approach for delivering pharmacotherapy to the back of the eye via the suprachoroidal space (SCS). The company's key product candidate, XIPERE, is a proprietary, preservative-free suspension of the corticosteroid triamcinolone acetonide formulated for administration via suprachoroidal injection, for the treatment of macular edema related with uveitis. The company is also developing Axitinib for Suprachoroidal Injection for administration to the SCS as a long-acting therapy for wet age-related macular degeneration.

Delcath Systems

Heritage Global

INVESCO PA VALUE MUNI INC TST

LEE ENTERPRISES INC

Maiden Holdings Ltd.

Nuveen New Jersey Dividend Advantage Municipal Fund

Nuveen Pennsylvania Investment Quality Municipal Fund Inc.

Pioneer Municipal High Income Advantage Trust

SPRUCE BIOSCIENCES INC

Zoom Video Communications, Inc.

Provider
InsiderInsights.com
InsiderInsights.com

Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.

Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.

InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.

Analysts
Jonathan Moreland

Other Reports on these Companies
Other Reports from InsiderInsights.com

ResearchPool Subscriptions

Get the most out of your insights

Get in touch